Cryoport and mitsubishi logistics corporation partner to bring temperature-controlled supply chain solutions to asia-pacific

Nashville, tenn., aug. 25, 2021 /prnewswire/ --  cryoport, inc.  (nasdaq: cyrx) ("cryoport" or the "company"), a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical research, pharmaceutical and cell and gene therapy markets, and mitsubishi logistics corporation ("mlc"), japan's leading pharma logistics company, today announced a multi-year strategic business alliance to create an integrated regenerative medicine supply chain partnership in japan.
CYRX Ratings Summary
CYRX Quant Ranking